These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15812644)

  • 21. Immunological studies on the cellular phenotype involved in corneal allograft rejection.
    Yang P; Gong X; Zhou H; Zhao M; Huang X; Xie C; Li F
    Chin Med J (Engl); 1999 Mar; 112(3):202-6. PubMed ID: 11593548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunohistochemical studies on wholemounts of the cornea and iris-ciliary body after corneal transplantation].
    Yang P; Gong X; Zhou H; Zhao M; Huang X; Xie C; Cao X; Jin H
    Zhonghua Yan Ke Za Zhi; 1998 Jul; 34(4):273-5, 19. PubMed ID: 11877206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine mRNA expression during experimental corneal allograft rejection.
    Torres PF; De Vos AF; van der Gaag R; Martins B; Kijlstra A
    Exp Eye Res; 1996 Oct; 63(4):453-61. PubMed ID: 8944552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
    Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
    Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rejection of corneal allografts].
    Guilbert E; Laroche L; Borderie V
    J Fr Ophtalmol; 2011 May; 34(5):331-48. PubMed ID: 21492957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanisms of corneal graft failure in the rat.
    Katami M
    Eye (Lond); 1995; 9 ( Pt 2)():197-207. PubMed ID: 7556718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunogenic privilege of corneal allografts.
    Niederkorn JY; Peeler JS; Ross J; Callanan D
    Reg Immunol; 1989; 2(2):117-24. PubMed ID: 2701814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA matching and corneal grafting.
    Batchelor JR; Casey TA; Werb A; Gibbs DC; Prasad SS; Lloyd DF; James A
    Lancet; 1976 Mar; 1(7959):551-4. PubMed ID: 55836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of allergic conjunctival inflammation on the allogeneic response to donor cornea.
    Flynn TH; Ohbayashi M; Ikeda Y; Ono SJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4044-9. PubMed ID: 17724186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of corneal allograft rejection on the long-term outcome of corneal transplantation.
    Coster DJ; Williams KA
    Am J Ophthalmol; 2005 Dec; 140(6):1112-22. PubMed ID: 16376660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunology of corneal allograft rejection: HLA-DR antigens on human corneal cells.
    Young E; Stark WJ; Prendergast RA
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):571-4. PubMed ID: 3884541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allograft survival enhancement using doxycycline in alkali-burned mouse corneas.
    Ling S; Li W; Liu L; Zhou H; Wang T; Ye H; Liang L; Yuan J
    Acta Ophthalmol; 2013 Aug; 91(5):e369-78. PubMed ID: 23387987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corneal Immunosuppressive Mechanisms, Anterior Chamber-Associated Immune Deviation (ACAID) and Their Role in Allograft Rejection.
    Treacy O; Fahy G; Ritter T; O'Flynn L
    Methods Mol Biol; 2016; 1371():205-14. PubMed ID: 26530803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation.
    Tanabe T; Ishida H; Horita S; Yamaguchi Y; Toma H; Tanabe K
    Transpl Immunol; 2011 Jul; 25(1):1-6. PubMed ID: 21616149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inappropriate expression of blood group antigens in hepatic allografts.
    Bloom S; Fleming K; Chapman R; Neuberger J; Hubscher S
    Hepatology; 1994 Apr; 19(4):876-81. PubMed ID: 8138260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of HLA-G in human cornea, an immune-privileged tissue.
    Le Discorde M; Moreau P; Sabatier P; Legeais JM; Carosella ED
    Hum Immunol; 2003 Nov; 64(11):1039-44. PubMed ID: 14602233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditions affecting enhanced corneal allograft survival by oral immunization.
    Ma D; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1835-46. PubMed ID: 9727406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation.
    Rayner SA; King WJ; Comer RM; Isaacs JD; Hale G; George AJ; Larkin DF
    Clin Exp Immunol; 2000 Oct; 122(1):109-16. PubMed ID: 11012626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of macrophage phenotype in rejected corneal allografts.
    Oh JY; Lee HJ; Ko AY; Ko JH; Kim MK; Wee WR
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7779-84. PubMed ID: 24159090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class II alloantigen induced on corneal endothelium. Role in corneal allograft rejection.
    Donnelly JJ; Orlin SE; Wei ZG; Raber IM; Rockey JH
    Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1315-20. PubMed ID: 2194989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.